Literature DB >> 26876072

[Early experience of laparoscopic pancreaticoduodenectomy on 66 cases].

Weiwei Jin1, Xiaowu Xu, Yiping Mou, Renchao Zhang, Chao Lu, Miaozun Zhang, Yucheng Zhou, Jingrui Wang.   

Abstract

OBJECTIVE: To evaluate the feasibility and safety of laparoscopic pancreaticoduodenectomy(LPD).
METHODS: Data of 66 patients from Sir Run Run Shaw Hospital undergoing LPD from September 2012 to September 2014 were reviewed. There were 44 male and 22 female with the mean age of (58.7±10.3) years and mean body mass index of (23.5±3.9)kg/m(2). Forty-five patients presented the symptoms and four of all had the history of abdominal surgery, including 2 cases of laparoscopic pancreatic surgery.
RESULTS: Of 66 patients underwent laparoscopic procedure, 1 patient underwent LPD combined with right hepatic resection, 1 patient underwent laparoscopic distal gastrectomy with LPD, and 1 patient underwent LPD after laparoscopic distal pancreatectomy. The mean operative time was (367±49) minutes. The mean blood loss was(193±126)ml. The rate of overall postoperative complications was 36.4%(24/66), with 4.5%(3/66) of B or C pancreatic fistula and 7.6% (5/66) of bleeding. The mean postoperative hospital stay was (18.9±12.1) days. Mean tumor size was (3.8±2.3) cm, and the mean number of lymph nodes harvested was (20.3±10.9). Forty-severn patients were diagnosed as pancreatic adenocarcinoma(n=18), cholangiocarcinoma(n=7), ampullary adenocarcinoma(n=21), and gastric cancer(n=1), respectively.
CONCLUSION: LPD is feasible and safe under the skilled hand.

Entities:  

Mesh:

Year:  2016        PMID: 26876072     DOI: 10.3760/cma.j.issn.0529-5815.2016.02.002

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  1 in total

1.  Laparoscopic pancreaticodoudenectomy: An excellent approach in elderly patients, a multicenter, comparative study.

Authors:  Maher Hendi; Yiping Mou; Chao Lu; Yu Pan; Bin Zhang; Ke Chen; Xiaowu Xu; Renchao Zhang; Yucheng Zhou; Weiwei Jin
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.